대한약학회:학술대회논문집 (Proceedings of the PSK Conference)
- 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
- /
- Pages.129.2-130
- /
- 2003
DA 11004, a synthetic IDPc inhibitor, inhibits the high fat high sucrose diet-induced obesity in C57BL/6 mice.
- Jeong, Mi-Young (Research Laboratories, Dong-A Pharm. Co. Ltd.) ;
- Shin, Chang-Yell (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Sohn, Jin-Bup (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Lee, In-Ki (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Son, Mi-Won (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Bae, Cheol-Jun (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Byun, Jong-Soo (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Kim, Dong-Sung (Research Laboratories, Dong-A Pharm. Co. Ltd) ;
- Kim, Soon-Hae (Research Laboratories, Dong-A Pharm. Co. Ltd.)
- 발행 : 2003.04.01
초록
Recently. it has been known that NADPH-dependent isocitrate dehydrogenase (IDPc) involves in the obesity through production of NADPH, an important cofactor. DA-11004 is a synthetic potent IDPc inhibitor that
키워드